In order to inoculate Indian population, which in numbers exceed 1.3 billion, a new policy has been developed by the Indian government that will come into impact on June 21. With states acquiring it tough to procure vaccines, the central government has taken reins in its hands to procure and handle funding of these Covid-19 vaccines. Under the new policy, the 75 per cent of the procured vaccines by the central government will straight go to states to be administered no cost whereas the remaining 25 per cent will be accessed by private hospitals.
Covid-19 new vaccination policy
- All citizens above the age of 18 years will be vaccinated no cost of expense at state and central government facilities. The no cost vaccination slab was earlier kept for priority groups which includes these above 45 years of age and healthcare workers.
- Vaccines are not no cost at private hospitals.
- At private hospitals, the expense for Covishield has been kept at Rs 750, Covaxin at Rs 1,410 and for Sputnik V- Rs 1,145. It is to note that the expense is inclusive of Rs 150 service charge.
- In circumstances exactly where folks are not capable to register for vaccines at the CoWIN portal, they can register with an onsite registration facility with government and private hospitals.
- States will get vaccines as per their population, transmission burden, progress and wastage of vaccination.
- The government will prioritise vaccination of healthcare/ frontline workers along with these above the age of 45 years, who are due to second dose. All states can choose the priority on their personal.
- For foreign vaccines by Pfizer, Moderna and Johnson & Johnson, no specific arrangement has been finalised however.
- In order to help economically weaker sections, RBI authorized non-transferable electronic vouchers will be offered that will help folks to get vaccination at private hospitals. This can be downloaded on mobiles for vaccination facilities to scan.
Meanwhile, the Centre had earlier asked states to procure 25 per cent of Covid-19 vaccination doses from the open marketplace that can be used to vaccinate folks belonging to the 18-44 year age group.